Are There Any Challenges in Using Nanotechnology for Vaccine Delivery?
Despite its advantages, there are challenges that need to be addressed:
Safety Concerns: The long-term safety of nanoparticles is not yet fully understood, and their interactions with biological systems need thorough investigation. Manufacturing Complexity: Producing nanoparticles with consistent quality and at scale can be technically challenging and expensive. Regulatory Hurdles: Regulatory frameworks for nanoparticle-based vaccines are still evolving, which can delay their approval and commercialization.
